Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Shrinking team NBB
FTE fell two years in a row, from 45.5 to 12.1.
-
Busy address KBO
19 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
ORTHOSPINE from Mechelen, company number BE0403015402, closed financial year 2025 with a result of € -95,051 after tax. For that financial year ORTHOSPINE recorded revenue of € 46,117 and equity of € -232,826. Compared with financial year 2024, the result moved from € -446,474 to € -95,051. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
€ -232,826
▼ € 95,051 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -95,051
▲ 79 % less loss than in 2024
Profit after tax over the fiscal year.
€ 67,574
▼ 57% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -807,264.
People and assets in 2025
12.1
▼ 2.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 630,000
▼ 48% vs 2024
€ 52,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 97,117
▼ 47% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 101 days on average.
€ 297,257
▲ 184% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 40,997,942 | € 2,774,060 | € 1,727,472 | € 46,117 | ▼ 97% |
| Profit after taxes | € -4,706,907 | € -162,620 | € -446,474 | € -95,051 | ▲ € 351,423 |
| Equity | € 3,692,195 | € 308,699 | € -137,775 | € -232,826 | ▼ € 95,051 |
| Total debts | € 16,276,375 | € 1,959,830 | € 1,424,882 | € 500,249 | ▼ 65% |
| Cash | € 1,497,250 | € 63,535 | € 156,272 | € 67,574 | ▼ 57% |
| Retained profit | € -807,805 | € -265,739 | € -712,213 | € -807,264 | ▼ € 95,051 |
| Bank debt | € 7,723,763 | € 285,604 | € 0 | € 0 | |
| Balance sheet total | € 20,988,621 | € 2,268,529 | € 1,287,107 | € 267,424 | ▼ 79% |
| Employees (FTE) | 85.8 | 45.5 | 14.5 | 12.1 | ▼ 2.4 |
Key figures of ORTHOSPINE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ORTHOSPINE?
What happened at ORTHOSPINE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Lana Gybels stepped down as director. NBB
- Diogo Santos de Lima stepped down as director. NBB
- Levico BV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 95,051. Source: NBB ↗
- Fh Impact Management BV stepped down as director. NBB
- Lana Gybels became a director. NBB
- D&Q Finexperts BV stepped down as director. NBB
- Diogo Santos de Lima became a director. NBB
In short
From € 4.7 million loss in 2022 to € 95,051 loss in 2025.
Paid € 135,785 in corporate taxes since 2022.
Pays suppliers within 101 days on average.
Management
The shares are held by Duomed Holding Benelux (100%).
Directors
According to the 2025 annual accounts
Director · represented by Frédéric Hoffmann
Also active at: DUOMED BELGIUM, ARCHER RESEARCH, Duomed Holding Benelux, Palex Duomed Holding, GP DUOMA
since 2024 · until 2025
Lana Gybels
Director
since 2025 · until 2031
Director · represented by Kristof Marivoet
Also active at: Duomed Holding Benelux, Palex Duomed Holding
since 2024 · until 2025
Director · represented by Geert Kuys
Also active at: DUOMED BELGIUM, Duomed Holding Benelux, Palex Duomed Holding, GP DUOMA
since 2023 · until 2029
Diogo Santos de Lima
Director
since 2025 · until 2031
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Vaartdijk 90
2800 Mechelen
Lennikse Baan 451
1070 Anderlecht
Active since 1 November 1962
Rue de l'Industrie 30c
1400 Nivelles
Active since 18 September 2014
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 19 companies are registered at this address.
All companies at this address →AXI
€ 26.7 million revenue · 2025
Palex Belgium same network
€ 113.3 million revenue · 2025
AMISTA
€ 2.5 million gross margin · 2025
Palex Healthcare Group Belgium same network
NESSI HOLDING
€ 391 gross margin · 2025
+14 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Domain
Domain
hospithera.com
Registered
1999-07-19
Registrar
Combell NV
Expires
2026-07-19
Website info
Features
Security
Details
- Company number
- 0403.015.402
- VAT number
- BE 0403.015.402
- Registered office
- Vaartdijk 90, 2800 Mechelen
- Names & denominations
- ORTHOSPINE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 January 1968
- Peppol
- Active · Active since 31 Mar 2026
- Contact
- hospithera.com [email protected]
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten